Diabetic kidney disease: Chronic kidney disease and diabetes - Preface

Diabetes Spectrum

Volumn 21, Issue 1, 2008, Pages 8-11

  Yee, Jerry ^{a,b,c,d,e,f,g,h,i,j,k,l}  

^a HENRY FORD HOSPITAL   (United States)

^b Greenfield Health Systems   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AMERICAN MEDICAL ASSOCIATION   (United States)

^e AMERICAN COLLEGE OF PHYSICIANS   (United States)

^f American Physiology Society

^g American Society of Nephrology

^h International Society of Nephrology   (Belgium)

ⁱ NATIONAL KIDNEY FOUNDATION   (United States)

^j Renal Physicians Association

^k Wayne County Medical Association

^l Michigan State Medical Society   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADYNAMIC BONE DISEASE; ANEMIA; BONE DISEASE; BONE METABOLISM; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; EDITORIAL; ETHNIC GROUP; GENETIC PREDISPOSITION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GLUCONEOGENESIS; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MICROALBUMINURIA; MINERAL METABOLISM; NEPHRITIS; NEPHROLITHIASIS; NEPHROSCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT;

EID: 40449085323     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.21.1.8     Document Type: Editorial

References (12)

1. National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease [article online]. Available at http://www.kidney.org/professionals/KDOQI/ guideline_diabetes. Accessed 13 October 2007
2. Levey AS, Bosch JP, Lewis JB, Green T, Rogers MN, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461-470, 1999
3. National Diabetes Education Program: The diabetes epidemic among African Americans [article online]. Available from http://www.ndep.nih.gov/diabetes/ pubs/FS_AfricanAm.pdf. Accessed 11 November 2007
4. Gansevoort RT, Vaziri RD, de Jong PE: Treatment of anemia of nephrotic syndrome with recombinant erythropoietin. Am J Kidney Dis 28:274-277, 1996
5. Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med 352:1011-1023, 2005
6. Lubowsky ND, Siegel R, Pittas AG: Management of glycemia in patients with diabetes mellitus and CKD. Am J Kidney Dis 50:865-879, 2007
7. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
8. McNair P: Bone mineral metabolism in human type 1 (insulin dependent) diabetes mellitus. Danish Med Bull 35:109-121, 1988
9. Orth SR, Ritz E: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127-1133, 1999
10. U.K. Prospective Diabetes Study Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
11. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW: The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 338:645-652, 1998
12. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393, 2003